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Abstract
Background: In IVF-ICSI cycles with single embryo transfer (SET), embryo selection for transfer
is of crucial importance. The present study aimed to define which embryo parameters might be
related to the implantation potential of advanced blastocysts.
Methods: Overall, in 203 cycles with SET, developmental characteristics of 93 implanted (group
A) and 110 non-implanted (group B) advanced blastocysts of good quality were compared. The
following developmental parameters were assessed in the two groups: normal fertilization,
developmental stage on day 5, number of blastomeres on day 2 and on day 3, fragmentation rate
on day 3, compaction on day 4 and cleavage pattern on day 2 and day 3.
Results: Expanded blastocysts compared to full blastocysts have higher implantation potential
(56.5% vs. 29.3%, p < 0.05). In group B, a higher proportion of advanced blastocysts showed
between 10% and 50% anucleated fragments on day 3 than in group A (23.6 vs 11.8, P = 0.03).
Advanced blastocysts with >10–50% fragments on day 3 showed a significant lower implantation
(29.7%) than those with ≤ 10%fragments (49.4%, P = 0.03). All the other parameters analysed were
comparable for the two groups.
Conclusion: Developmental stage on day 5 and fragmentation rate on day 3 were related to the
implantation potential of advanced blastocysts and sho u l d  a l s o  b e  t a k e n  i n t o  a c c o u n t  i n  t h e
selection of the best advanced blastocyst for transfer.
Background
The ultimate goal of assisted procreation is the birth of a
singleton liveborn infant. Growing concerns have been
raised regarding the risks of multiple pregnancies which
consist of approximately 30% of the deliveries after
assisted reproductive technology (ART) [1]. The only way
to achieve this goal is to move towards single embryo
transfer policy [2]. In order to prevent a significant
decrease in pregnancy and delivery rates when only one
embryo is transferred, the selection of that embryo for
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transfer should be optimal to ensure a high implantation
rate.
There is general agreement that a positive correlation
exists between embryo quality and pregnancy rates [3].
Several studies, either on day 2 [4-9] have attempted to
quantify the implantation potential of an embryo by
means of scoring systems based on different embryologi-
cal parameters such as blastomere size, cell number, cleav-
age speed, degree of fragmentation. These factors have
been combined in a variety of different ways to yield
embryo-scoring systems that could predict pregnancy
[10,11]. Van Royen et al. reported an interesting
approach, in which they estimated the implantation
potential of day 3 embryos, comparing all the embryos
leading to an ongoing implantation to those that did not
result in a pregnancy [12].
On the other hand, the feasibility of culturing the human
embryo to a viable blastocyst, using appropriate sequen-
tial media, allows for the identification of those embryos
with a higher developmental potential [13]. Furthermore,
to perform embryo transfer at the blastocyst stage has
additional advantages such as better synchronization
between embryo developmental stage and uterine envi-
ronment [14], and decreased uterine contractility [15].
However, by extending the embryo culture to day-5 there
is a risk that the embryos of some patients could not reach
that stage and consequently the cancellation of transfer
will deprive them from a chance of pregnancy. Neverthe-
less, controversy still exists in literature regarding the mer-
its of blastocyst transfer [16,17].
So far, no attempt has been made to correlate specific
embryo parameters of blastocysts and their implantation
potential. Moreover, single embryo transfer offers the pos-
sibility of comparing two embryo populations of
implanted and non-implanted embryos, thus eliminating
biases by excluding transfers where only one embryo
implanted. This was the case in previous studies based on
double embryo transfers (DET) [12].
The aim of the present retrospective study was to assess
whether day2 – day3 – day4, and day5 embryo parameters
of selected advanced blastocysts are related to their
implantation potential. In cycles with SET on day 5, devel-
opmental characteristics of implanted and non-implanted
blastocysts were compared. This may provide evidence on
the selection criteria of the advanced blastocyst with the
highest implantation potential in cases where more than
one advanced blastocyst is available on the day of transfer.
Methods
Study design
Between January 2001 and March 2004, 312 single
embryo transfers were performed on day 5 in patients
under 36 years old in their first or second IVF attempt.
Cycles with preimplantation genetic diagnosis (PGD),
frozen embryo transfer cycles and cycles with frozen or
non-ejaculated sperm were not included.
In order to study which embryo characteristics – observed
during the culture period preceding the blastocyst transfer
and on the fifth day of the embryo culture – may interfere
with the implantation potential of the blastocyst, we
reduced the variability in quality of the transferred blasto-
cysts and we included in the study only good quality blas-
tocysts. Therefore, only the advanced blastocysts of good
quality (BL3 and BL4 according to Gardner and School-
craft), [18], with type A or B of inner cell mass and for tro-
phectoderm (n = 203, 65.1%), were considered for the
study [18]. Ninety-three implanting (group A) and one
hundred and ten non-implanting blastocysts (group B)
were compared for the analysis.
Transfer with compacted embryos (n = 25, 8%), with early
blastocysts or with advanced blastocysts of inferior quality
(n = 84, 26.9%) were excluded.
Assisted reproduction techniques
Female patients underwent multifollicular ovarian stimu-
lation (multi-FOS) with a GnRH antagonist/recombinant
gonadotrophin protocol. The details about stimulation
protocol have been published elsewhere [19]. When three
or more follicles reached a size of ≥ 17 mm in diameter,
final oocyte maturation was induced by the administra-
tion of 10 000 IU human chorionic gonadotrophin
(hCG). Oocyte retrieval was carried out 36 h later by vag-
inal ultrasound-guided puncture of ovarian follicles.
Standard IVF/ICSI procedures were applied according to
Van Landuyt et al. [20]. For the IVF procedure, each cumu-
lus-oocyte complex was placed in a 25 µl droplet of ferti-
lization medium covered by lightweight paraffin oil.
Cumulus-oocyte complexes were inseminated within 3–4
hours after retrieval by adding 5000 progressively motile
spermatozoa (type A + B motility).
For the ICSI procedure, denudation of the cumulus cells
was carried out by exposure to 10 IU of hyaluronidase
(type VIII, Sigma Chemical Company, St. Louis, Mo) [21].
Nuclear maturation of the oocytes was checked after den-
udation. Only mature, metaphase II oocytes were used for
ICSI as described previously [22]. Injected oocytes were
placed in 25 µl droplets of cleavage medium and incu-
bated under an atmosphere of 6% CO2, 5% O2 and 89%
N2 at 37°C. Two different sequential media were used forReproductive Biology and Endocrinology 2007, 5:2 http://www.rbej.com/content/5/1/2
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oocyte and embryo culture (GII series from Vitrolife,
Göteborg, Sweden or BlastAssist System from MediCult,
Jyllinge, Denmark).
Evaluation of fertilization and embryo quality
Survival and fertilization of the oocytes were checked 16–
19 h after injection using an inverted microscope at 400×
magnification. The zygotes were scored taking into
account number, position and size of the pronuclei as
well as number and location of the nucleolar precursor
bodies within the pronuclei. Normal fertilization was
confirmed by the presence of two pronuclei (PN) with
two distinct or fragmented polar bodies. Fertilization rate
was expressed as the percentage of 2PN oocytes or the
number of inseminated (IVF) or injected (ICSI) oocytes.
Embryo development and embryo quality were assessed
daily until the moment of intrauterine transfer. Embryo
quality was scored according to the following criteria: the
number of blastomeres, the rate of fragmentation, cell-
size symmetry, multinucleation, the degree of compac-
tion, granulation and the presence of vacuoles. We con-
sidered five categories of fragmentation: type 0 embryos
had no anucleated fragments, type 1 embryos showed
>0% – ≤10% fragments, type 2 embryos showed >10% –
≤20% fragments, type 3 embryos showed >20% – ≤50%
fragments and type 4 embryos showed >50% fragments
(type 4 was not transferred). Day-2 and Day-3 evaluations
were carried out 43–46 hours and 65–68 hours after
insemination/injection respectively. In the morning of
day 3, embryos were rinsed and transferred to individual
25 µl fresh blastocyst medium droplets covered by paraf-
fin oil.
Embryo parameters analysed for implanted and non-
implanted advanced blastocysts
The two groups were compared for the following develop-
mental parameters: number of blastomeres on day 2 (<4
cells, 4 cells, >4 cells) and on day 3 (<8 cells, 8 cells, >8
cells); fragmentation rate on day 3 (≤10% and >10–50%);
compaction on day 4 (non-compacting, compacting +
compacted, early blastocyst), and cleavage pattern. The
latter was evaluated in two different ways. First, the cleav-
age stage on day 3 (<8 cells, 8 cells, > 8 cells, other pattern)
of the only embryos that had 4 cells on day 2 was investi-
gated. Secondly, the cleavage stage on day 2 (<4 cells, 4
cells, > 4 cells) of the only embryos that had 8 cells on day
3 was evaluated.
Evaluation of blastocyst quality
Blastocyst evaluation was performed on day 5 of in-vitro
culture according to the Gardner and Schoolcraft criteria
[19]. This blastocyst scoring system is based on three
parameters: (i) blastocoel formation and degree of expan-
sion, (ii) development of the inner cell mass (ICM) and
(iii) development of the trophectoderm (TE). Only
advanced blastocysts (type 3 full blastocysts and type 4
expanded blastocysts) with a good quality inner cell mass
(many cells tightly packed type A or several cells loosely
grouped type B) and multicellular trophectoderm (many
cells forming a cohesive epithelium type A or few cells
forming a loose epithelium type B) were included in our
study (BL3AA, BL3AB, BL3BA, BL3BB, BL4AA, BL4AB,
BL4BA, BL4BB). On the morning of day 5, the embryolo-
gist selected the "best" blastocyst for transfer. This choice
was based on several criteria. Preferably a full or an
advanced blastocyst was selected, with a clear inner cell
mass and several cells in the trophectoderm. If none of the
embryos fulfilled these criteria, early blastocysts or com-
pacted embryos were transferred.
Embryo transfer and pregnancy
Embryo transfer was carried out on day 5. In the present
study, only SETs were taken into consideration. The first
pregnancy test was performed 14 days after the oocyte
retrieval. A pregnancy was confirmed when two consecu-
tive hCG concentrations of >10 IU/L were measured. Clin-
ical pregnancy was defined by intrauterine gestational sac
with fetal heartbeat, observed by vaginal ultrasound at 7
weeks of gestation. The implantation rate was considered
as the percentage of fetal sacs with heartbeat on the
number of embryos transferred.
Statistical analysis
Fisher's exact test was used to analyse nominal variables
(fragmentation rate on day 3, compaction degree on day
4 and cleavage pattern, number of blastomeres on day 2
and on day 3, type of insemination procedure) in the
form of frequency tables. Normally distributed (Kol-
mogorov-Smirnov Test with Lilliefors correction) metric
variables (gonadotrophins total dose, number of oocytes,
GV, MI, MII and 2PN) were tested with the t-test for inde-
pendent samples, while non-normally distributed metric
variables (age of patients) were analysed with the Mann-
Whitney U test. All tests were two-tailed with a confidence
level of 95% (p < 0.05). Values are expressed as mean ±
standard error of the mean (SEM). Regression analysis
performed where appropriate.
Results
Overall 203 advanced blastocysts were considered. The
characteristics of two embryo populations were com-
pared: 93 implanted embryos (group A) and 110 non-
implanted embryos (group B). The implantation rate was
45.8%.
Comparing group A with group B, there was no difference
with regard to the patients' age (29.7 ± 0.3 vs. 30.1 ± 0.3),
the total dose of gonadotrophins used (1633 ± 69 vs.
1720 ± 73) and the type of insemination procedure per-
formed: ICSI (66.7% vs. 70.0%), IVF (31.2% vs. 26.4%)Reproductive Biology and Endocrinology 2007, 5:2 http://www.rbej.com/content/5/1/2
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and ICSI in combination with IVF (2.2% vs. 3.6%). The
two groups were also comparable with relation to the
mean number of COCs retrieved and the mean percent-
ages of GV, MI oocytes and MII oocytes per cycle. Further-
more, similar results were found with regard to normal
fertilization rate (%2PN) (Table 1).
The individual implantation potential of each of the eight
categories of advanced blastocysts is shown in Table 2.
Comparing expanded blastocysts (BL4) to full blastocysts
(BL3) (Table 2), it seems that BL4 stage has better preg-
nancy outcome than BL3 stage, and certainly a top quality
BL4 embryo (BL4AA & BL4AB) has a higher implantation
potential than a top quality BL3 embryo (BL3AA &
BL3AB) (52.4% vs. 28.3%, p < 0.05, respectively).
The comparison of several embryo parameters revealed
that the fragmentation rate on day 3 was significantly dif-
ferent for groups A and B (Table 2). The proportion of
advanced blastocysts with >10% fragmentation on day 3
was significantly higher (P = 0.03) in group B than in
group A (23.6% vs 11.8%). As a result, advanced blasto-
cysts with >10% fragments on day 3 showed a signifi-
cantly (P = 0.03) lower implantation rate than those with
≤10% fragments (29.7% vs 49.4%) Figure 1.
No differences were observed in the number of blast-
omeres on day 2 and on day 3, and in the degree of com-
paction between the implanted and non-implanted
blastocysts (Table 3). The proportion of the three embryo
stage categories on day 2 (<4 cells, 4 cells, >4 cells), on day
3 (<8 cells, 8 cells, > 8 cells) and on day 4 (non-compact-
ing, compacting + compacted, early blastocyst) was simi-
lar for group A and for group B. Similar results were found
for the cleavage patterns. From all the 4-cell embryos on
day 2, the proportion that reached < 8 cells, 8 cells and >
8 cells on day 3 was comparable for the implanted and
non-implanted embryos. From the 8-cell embryos on day
3, almost all of them showed 4 cells on day 2, both in
group A and in group B. The proportion of advanced blas-
tocysts that showed 4 blastomeres on day 2 and 8 blast-
omeres on day 3 was the same in the implanted and non-
implanted populations (72.5% group A vs 66.3% group
B) (Table 3).
Multivariate logistic regression analysis was performed
with dependent variable the achievement of implantation
or not and independent variables the fragmentation rate
on day-3, the developmental stage on day-5 (BL3 or BL4)
and the age. The only covariate that was statistically signif-
icant was the type of advanced blastocyst on the fifth day
of embryo culture (p = 0.032).
A logistic regression analysis failed to find any statistically
significant effect of the two sequential media on preg-
nancy occurrence (data not shown).
Discussion
The selection of embryos with a high chance of implanta-
tion is a difficult task in human assisted reproduction.
One of the proposed methods is to extend the culture
period up to the blastocyst stage. On day 5, the morpho-
logical criteria for selection, although still subjective [23],
eliminate embryos with impaired development beyond
the 8-cell stage and reduce the risk of transferring a top-
quality embryo with chromosomal abnormalities [24].
Furthermore, with the increased application of single
embryo transfer, the selection of the "best" embryo has
become an urgent need.
To the best of our knowledge, this is the first study which
has attempted to assess whether embryo characteristics of
Table 1: Patient and cycle characteristics
Group A (100% implantation) Group B (O% implantation) Statistics
No. of Patients (embryos) 93 110
Age1 29.7 ± 0.3 30.1 ± 0.3 NS
Gonadotrophins total dose1 1633 ± 69 1720 ± 73 NS
Type of insemination procedure No. (%)
 ICSI 62 (66.7) 78 (71.0) NS
 IVF 31 (33.3) 32 (29.0)
No. of oocytes1 13.6 ± 0.7 13.0 ± 0.6 NS
No. of GV2 1.0(6.8) 0.9 (6.4) NS
No. of MI2 0.2 (1.7) 0.3 (2.3) NS
No. of MII2 12.0 (89.8) 11.0 (86.1) NS
No. of 2PN2 8.2 (64.1) 7.5 (58.9) NS
Blastulation rate% 55% 49% NS
SEM = standard error of the mean
NS = not significant
1Values expressed as mean ± SEM
2Values expressed as mean number (%)Reproductive Biology and Endocrinology 2007, 5:2 http://www.rbej.com/content/5/1/2
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Implantation potential of advanced blastocysts with respect to fragmentation rate on day 3 (≤ 0% vs. >10–50%) Figure 1
Implantation potential of advanced blastocysts with respect to fragmentation rate on day 3 (≤10% vs. >10–50%).
Table 2: Effect of blastocyst score on pregnancy outcome
Different categories of advanced blastocysts Not implanted % (n) Implanted % (n) P value
Total BL3 (n = 81) (BL3AA, BL3AB, BL3BA, BL3BB) 70.3% (57) 29.3%(24)
Total BL4 (n = 122) (BL4AA, BL4AB, BL4BA, BL4BB) 43.4% (53) 56.5%(69) p < 0.05
Top quality BL3 (n = 76) (BL3AA, BL3AB) 65.4% (53) 28.3%(23)
Top quality BL4 (n = 109) (BL4AA, BL4AB) 36.8% (45) 52.4%(64) p < 0.05
Individual implantation rate of advanced blastocysts
• BL3AA (n = 62) 67.7% (42) 32.3% (20)
• BL3AB (n = 14) 78.6% (11) 21.4% (3)
• BL3BA (n = 2) 50% (1) 50% (1)
• BL3BB (n = 3) 100% (3) 0 P = 0.02
• BL4AA (n = 107) 43% (46) 57% (61)
• BL4AB (n = 4) 25% (1) 75% (3)
• BL4BA (n = 6) 33.3% (2) 66.7% (4)
• BL4BB (n = 5) 80% (4) 20% (1)Reproductive Biology and Endocrinology 2007, 5:2 http://www.rbej.com/content/5/1/2
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advanced good quality blastocysts are related to their
implantation potential in a single embryo setting. Per-
forming the study on only SET's eliminates the bias
involved in comparing populations with more than one
implanted embryo or more than one non-implanted
embryo from the same patient.
Our findings suggest that the developmental stage of an
advanced blastocyst quantitated by a systematic scoring
system, affects its implantation potential, resulting in bet-
ter pregnancy outcome with an advanced blastocyst stage
BL4 (AA or AB) than a full blastocyst BL3 (AA or AB),
although all these embryos are characterised as top-qual-
ity embryos. The above finding confirms previous reports
where patients with expanded blastocysts had higher clin-
ical pregnancy and live birth rates compared with patients
with non-expanding blastocysts (morulae and early blast-
ocysts) [25]. It seems rational that we need to re-evaluate
our quality ranking according to the grading score for
advanced blastocysts since the real expanded blastocysts
with a good quality inner cell mass and multicellular tro-
phectoderm (BL4AA and BL4AB) represent a subcategory
within the advanced blastocysts with really optimum
quality as they can achieve implantation rates as high as
52.4%. Similarly, Gardner et al have found implantation
rates as high as 69% by transferring two blastocysts with
score ≥3AA, resulting in the suggestion that in the pres-
ence of two top-scoring blastocysts, single embryo transfer
should be implemented in order to avoid multiple preg-
nancies [26]. The current study confirms the above pro-
posal and furthermore highlights the higher efficacy of an
expanded blastocyst compared to a full blastocyst.
In addition, we observed that the fragmentation rate on
day 3 was related to the implantation potential of the
advanced blastocysts selected for transfer on day 5. As a
result, blastocysts with >10% fragments on day 3 showed
a significantly lower implantation rate than those with
≤10% fragments (29.7% vs 49.4%) (Figure 1). Although
this significance disappears in the multivariate analysis,
that result suggests that fragmentation on day 3 should be
more taken into account in the selection of the best blast-
ocyst for transfer in patients where more than one
advanced blastocyst of good quality is available on the
day of transfer. If only one advanced blastocyst with frag-
mentation is available, it remains unclear whether this
Table 3: Embryo parameters analysed in the implanted (Group A) and non-implanted (Group B) advanced blastocysts
Group A n = 93 Group B n = 110 Statistics
Number of blastomeres on day 2
 < 4 cells 2 (2.2%) 4 (3.6%) NS
 4 cells 80 (86.0%) 95 (86.4%)
 > 4 cells 11 (11.8%) 11 (10.0%)
Number of blastomeres on day 3
 <8 cells 3 (3.2%) 7 (6.4%) NS
 8 cells 63 (67.7%) 67 (60.9%)
 >8 cells 27 (29.0%) 36 (32.7%)
Fragmentation rate on day 3
 <10% 82 (88.2%) 84 (76.4%) 0.03
 ≥ 10–50% 11 (11.8%) 26 (23.6%)
Embryo stage on day 4
 Not compacted 3 (3.2%) 4 (3.6%) NS
 Compacted 68 (73.1%) 73 (66.4%)
 Early blastocysts 22 (23.7%) 33 (30.0%)
Cleavage pattern: 4 cells on day 2 vs. number of cells on day 3 n = 80 n = 95
 4 cells – < 8 cells 3 (3.7%) 5 (5.2%) NS
 4 cells – 8 cells 58 (72.5%) 63 (66.3%)
 4 cells – > 8 cells 19 (23.7%) 27 (28.4%)
Cleavage pattern: 8 cells on day 3 vs. number of cells on day 2 n = 63 n = 67
 8 cells – < 4 cells 2 (3.2%) 2 (3.0%) NS
 8 cells 4 58 (92.1%) 63 (94%)
 8 cells – > 4 cells 3 (4.8%) 2 (3.0%)Reproductive Biology and Endocrinology 2007, 5:2 http://www.rbej.com/content/5/1/2
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embryo should be selected in preference to an early blast-
ocyst with minimal fragmentation. However, this issue is
beyond the scope of the present study.
Eighty percent of the transferred advanced blastocysts in
the present study had less than 10% fragmentation on day
3. This seems logical as blastocyst formation decreases
with increasing fragmentation rate [27,28]. Although
embryos with > 10% fragmentation may also reach the
advanced blastocyst stage, their fragmentation rate still
had a negative impact on implantation. Since the frag-
mentation rate does not decrease during development
[29], the impact of this parameter was only taken into
consideration on day 3. It is well known that a significant
decrease in implantation rate and pregnancy rate occur
with increased fragmentation, especially between 10–
50%, both on day 2 and day 3 [27,28,30]. Cytogenetic
data have shown that 47% of highly fragmented (20–40%
of fragmentation) embryos are chromosomally abnormal
[31]. In addition, fragments positioned in the cleavage
cavity may cause distortion of division planes leading to
abnormal compaction, cavitation, and blastocyst forma-
tion [27].
With the exception of fragmentation, all other parameters
of embryo quality were comparable for the population of
implanted and not-implanted advanced blastocysts. No
differences between the two groups were observed for the
distribution in different categories of number of blast-
omeres on day 2 and on day 3, compaction rate and cleav-
age pattern. However, it should be taken into account that
in case of elective single advanced blastocyst transfer,
embryologists preferentially opt to transfer embryos hav-
ing 4 cells on day 2 and 8 cells on day 3.
Also we attempted to investigate whether advanced blast-
ocysts with the ideal cleavage pattern (4 cells on day 2 to
8 cells on day 3) had an increased implantation potential
compared to advanced blastocysts of the same quality
with other cleavage patterns. Blastocysts with an ideal
cleavage pattern (4 cells on day 2 to 8 cells on day 3)
seemed not to have increased implantation potential
compared with blastocysts with another pattern of divi-
sion. However, an embryo with cleavage pattern 4 cells-8
cells might be more likely to become an advanced blasto-
cyst compared with other cleavage patterns. The above
findings suggest that, at the advanced blastocyst stage, the
embryo has already reached a high developmental status,
and that the morphological parameters of the advanced
blastocysts on day-5 itself is of prior importance, rather
than its previous cleavage pattern.
Since the implantation rate was as high as 45.8%, it may
be assumed that the selection of the embryo for transfer
on day 5 was carried out correctly. It should not be over-
looked, however, that embryo quality is not the only fac-
tor related to success in IVF/ICSI cycles. Once a high-
quality blastocyst has been selected, it seems that other
than embryological characteristics further determine the
implantation potential of the selected blastocyst (female
age, endometrial receptivity, previous patient history).
[32,33].
Conclusion
The current study has highlighted that once a patient has
high-quality blastocysts, the transfer of an advanced blas-
tocyst may result in implantation in almost half of the
patients. The only embryological parameters that seemed
to have an effect on the implantation ability in this study
were the developmental stage on day-5 and the fragmen-
tation rate on day-3. Which morphological parameter is
of prior importance to improve the implantation poten-
tial in day 5 embryo transfer needs to be further investi-
gated.
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